Skip to main content
. 2021 Jun 21;10(1):1938476. doi: 10.1080/2162402X.2021.1938476

Figure 2.

Figure 2.

Prognosis of cancer patients with PD-L1 expression on CTCs in the peripheral blood. A, Pooled HRs and 95% CI for OS. B, Pooled HRs, and 95% CI for PFS. C, Pooled HRs, and 95% CI for OS in the subgroup that did not use ICI therapy. D, Pooled HRs and 95% CI for OS in the subgroup that uses ICI therapy